EIF3A and hepatocellular carcinoma: In this study, we report one of these tumor-associated autoantibodies, anti-eukaryotic translation initiation factor 3 subunit A (EIF3A) autoantibody, designated as XC90, and its potential application as a diagnostic biomarker of human HCC.